NSUN2 and acute myeloid leukemia: In AML, NSUN2 stabilizes the mRNA of phosphoglycerate dehydrogenase (PHGDH) and SHMT2—two key enzymes in the serine/glycine biosynthesis pathway—by regulating m5C modification, thereby enhancing the expression of PHGDH167.